Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

IntroductionA direct causal link between Sudden Cardiac Death (SCD) and COVID-19 is unproven, although current data suggest a plausible association.AimThis study aims to map and analyze the intersection of research on sudden cardiac death and COVID-19 through a comprehensive bibliometric analysis.MethodologyThis study searched the literature by applying the keywords “COVID-19” AND “Sudden Cardiac Death (SCD)”.

Sudden Cardiac Death 105

Sudden Cardiac Death COVID-19 Article Research 105

HCPLive

NOVEMBER 17, 2024

Obesity-related ischemic heart disease deaths rose from 1999 to 2020, particularly in middle-aged men and Black adults, per CDC WONDER data.

Obesity 111

Obesity Heart Disease 111

American Heart News - Heart News

NOVEMBER 17, 2024

Research Highlights: The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not significantly impact the rate of death, new heart attack or stroke. More research is needed to further.

Heart Failure 98

Heart Failure Blood Pressure Heart attacks Heart Attack 98

HCPLive

NOVEMBER 17, 2024

Oussama Wazni, MD, discusses the results of the OPTION trial examining LAAC in atrial fibrillation as well as its reception as AHA 2024.

Atrial Fibrillation 105

Atrial Fibrillation 105

JAMA Cardiology

NOVEMBER 17, 2024

This cross-sectional study uses National Health and Nutrition Examination Survey data to examine the number of US adults eligible for semaglutide across all current indications.

94

94

HCPLive

NOVEMBER 17, 2024

Findings from the first and only controlled study for macrophage activation syndrome were presented at the ACR Convergence.

105

105

Med Page Today

NOVEMBER 17, 2024

(MedPage Today) -- CHICAGO -- A mineralocorticoid receptor antagonist (MRA) was unable to further improve 3-year outcomes of acute myocardial infarction (MI) in the modern era, based on the CLEAR OASIS 9 trial. Among heart attack survivors without.

Myocardial Infarction 93

Myocardial Infarction Heart attacks Heart Attack Outcomes 93

American Heart News - Heart News

NOVEMBER 17, 2024

Research Highlights: Pacemakers reconditioned with an FDA-approved protocol worked as well as new devices in a study of nearly 300 people in seven low- and middle-income countries. The study compared the function and safety of reconditioned pacemakers.

Pacemaker 91

Pacemaker Research 91

HCPLive

NOVEMBER 17, 2024

Barry A. Borlaug, MD describes the beneficial effect of tirzepatide on circulatory pressure-volume overload and end-organ damage in patients with HFpEF and obesity.

Obesity 98

Obesity 98

Med Page Today

NOVEMBER 17, 2024

(MedPage Today) -- CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the route of anticoagulation to mitigate subclinical brain infarcts, according to the BRAIN-AF trial.

AFIB 91

AFIB Atrial Fibrillation Research 91

HCPLive

NOVEMBER 17, 2024

Electronic messages highlighting cardiovascular benefits of flu shots increased vaccination rates by 1.8% in heart attack survivors.

Heart attacks 98

Heart attacks Heart Attack 98

American Heart News - Heart News

NOVEMBER 17, 2024

Research Highlights: An electronic message to "nudge" patients to get a flu vaccine highlighting the cardiovascular benefits of flu shots improved vaccination rates among more than two million adults in three clinical trials in Denmark. The research.

Heart attacks 86

Heart attacks Heart Attack Research 86

HCPLive

NOVEMBER 17, 2024

Gandhi discussed examining social security disability rates and how SSD criteria may clash with a trait disease like fibromyalgia.

97

97

JAMA Cardiology

NOVEMBER 17, 2024

This cohort study evaluated adoption rates of sodium-glucose cotransporter-2 inhibitors at US hospitals for patients with heart failure and mildly reduced or preserved left ventribular ejection fraction.

Preserved Ejection Fraction 73

Preserved Ejection Fraction Heart Failure Hospital 73

HCPLive

NOVEMBER 17, 2024

Just discussed data from 2 studies demonstrating efficacy of AI assessment compared to clinician assessment.

75

75

The New England Journal of Medicine

NOVEMBER 17, 2024

In a study involving patients with Danon disease, AAV9.LAMP2B gene therapy appeared to be safe, increased cardiac LAMP2 expression, and was associated with clinical improvement over 24 to 54 months.

69

69

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

BackgroundThe serum lactate/albumin ratio (LAR) is commonly employed for monitoring and evaluating the prognosis of critically ill patients. Both elevated lactate levels and decreased albumin levels may reflect the body's stress response and inflammatory reaction. Coronary heart disease (CHD), with common complications including myocardial infarction, arrhythmia, heart failure, is one of the leading causes of global death.

ICU 59

ICU Heart Disease Myocardial Infarction Biomarkers 59

American Heart News - Heart News

NOVEMBER 17, 2024

Research Highlights: A study of three pills that combined two types of blood-pressure-lowering medications into one pill found that all combinations worked equally well among adults in India. Results from the TOPSPIN trial found that any.

Blood Pressure 64

Blood Pressure Research 64

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

BackgroundAnemia is a common complication in patients with heart failure and is associated with left ventricular systolic dysfunction. However, its role in right ventricular (RV) function has not been evaluated.MethodsWe retrospectively analyzed the electronic medical data of 1,014 Heart Failure with Preserved Ejection Fraction (HFpEF) patients to evaluate the relationship between anemia and RV dysfunction in patients with HFpEF and whether this relationship is influenced by classical risk facto

Preserved Ejection Fraction 59

Preserved Ejection Fraction Heart Failure Tricuspid Risk Factors 59

American Heart News - Heart News

NOVEMBER 17, 2024

Research Highlights: The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries involving bypass did not result in significant benefits at preventing death, stroke or organ injury.

Research 64

Research Stroke Strokes 64

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

BackgroundWeight-adjusted waist circumference index (WWI) is a novel index related to obesity and has been associated with the risk and prognosis of several diseases. The aim of the study was to determine the association between WWI and myocardial infarction.MethodsThe study analyzed cross-sectional data from 31,535 participants derived from the 1999–2014 National Health and Nutrition Examination Survey (NHANES) dataset.

Myocardial Infarction 59

Myocardial Infarction BMI Angina Obesity 59

American Heart News - Heart News

NOVEMBER 17, 2024

Research Highlights: Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and blood clot prevention in patients after heart valve replacement surgery as warfarin, the current.

Blood Clot 64

Blood Clot Heart Valves Stroke Strokes 64

Med Page Today

NOVEMBER 17, 2024

(MedPage Today) -- CHICAGO – A CRISPR-Cas9-based investigational therapy was linked with a drop in serum transthyretin (TTR) levels in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), according to phase I data. A single.

Cardiomyopathy 59

Cardiomyopathy 59

HCPLive

NOVEMBER 17, 2024

Kim explains how poor sleep is linked to negative impacts on mental health, physical health, and frailty after liver transplantation.

Transplant 59

Transplant Outcomes 59

Nature Reviews - Cardiology

NOVEMBER 17, 2024

Nature Reviews Cardiology, Published online: 18 November 2024; doi:10.1038/s41569-024-01100-3 Cholesterol crystals (CCs) have a pathogenic role in various cardiovascular diseases, particularly atherosclerosis. In this Review, Boisvert and colleagues describe the mechanisms underlying CC formation and the role of CCs in cardiovascular disease, as well as therapeutic approaches aimed at reducing CC-mediated atherosclerotic burden.

Cholesterol 54

Cholesterol Atherosclerosis Cardiovascular Disease 54

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

BackgroundAllergy to iodine contrast agents has long been a contraindication for balloon pulmonary angioplasty (BPA). We report the successful zero-contrast BPA procedure of a patient with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and severe iodine allergy using real-time fusion of computed tomography angiography (CTA) with x-ray fluoroscopy.Case presentationA 62-year-old woman with CTEPH who developed a severe allergic reaction after the first BPA procedure.

Angioplasty 59

Angioplasty Pulmonary Technology Hypertension 59

Heart Sisters

NOVEMBER 17, 2024

The ebbs and flows of diagnosis: 'Learning you have a serious medical condition might qualify as an immediate crushing ebb, but oddly enough, I felt instead an overwhelming flow of relief. These people were taking me seriously.

Heart Disease 55

Heart Disease 55

American College of Cardiology

NOVEMBER 17, 2024

Do electronic "nudges" or decision-support systems impact patient and clinician decision-making? Two separate studies presented at AHA 2024 explore answers to this question, specifically in the areas of flu vaccination rates and optimization of lipid-lowering therapies.

Patient Care 52

Patient Care Article 52

HCPLive

NOVEMBER 17, 2024

Compared with non-Hispanic White patients, racial/ethnic minority patients were more likely to be removed from the waitlist and not receive a transplant.

Transplant 52

Transplant 52

American College of Cardiology

NOVEMBER 17, 2024

The goal of the CLEAR SYNERGY (OASIS 9) spironolactone trial was to determine the potential cardiovascular (CV) benefit of spironolactone following percutaneous coronary intervention (PCI) for ST-segment or large non–ST-segment elevation myocardial infarction (STEMI or NSTEMI, respectively) regardless of post-MI left ventricular ejection fraction (LVEF).

Myocardial Infarction 52

Myocardial Infarction STEMI Article 52

Med Page Today

NOVEMBER 17, 2024

(MedPage Today) -- CHICAGO -- Edoxaban (Savaysa) appeared at least on par with warfarin for 12-week thromboembolic prophylaxis after bioprosthetic valve surgical implant in a Japanese trial with a population largely in sinus rhythm, but small.

52

52

American College of Cardiology

NOVEMBER 17, 2024

Edoxaban was comparable to warfarin in preventing stroke or systemic embolism and intracardiac thrombus in patients with non-valvular atrial fibrillation (AFib) within three months after bioprosthetic valve surgery, based on preliminary findings from the ENBALV trial presented at AHA 2024.

AFIB 52

AFIB Atrial Fibrillation Embolism Stroke 52

Med Page Today

NOVEMBER 17, 2024

(MedPage Today) -- CHICAGO -- Artificial intelligence (AI) assistance for echocardiography is becoming better validated and proving mettle for clinical use. AI-fed echocardiography videos were able to complete 18 tasks at once, classifying patients.

52

52

HCPLive

NOVEMBER 17, 2024

Ankeet Bhatt, MD, MBA, ScM, provides additional insight into NUDGE-FLU data he presented at AHA 2024.

52

52

Circulation

NOVEMBER 17, 2024

Circulation, Volume 150, Issue 21 , Page 1732-1736, November 19, 2024.

Circulation 49

Circulation 49

HCPLive

NOVEMBER 17, 2024

Christian. T. Ruff, MD, MPH describes an analysis of AZALEA-TIMI 71 demonstrating the substantial benefit of abelacimab on bleeding outcomes in patients on antiplatelet therapy.

Outcomes 52

Outcomes 52

Circulation

NOVEMBER 17, 2024

Circulation, Volume 150, Issue 21 , Page e466-e466, November 19, 2024.

Circulation 49

Circulation 49